Samsung Medical Center
| Corea del Sud | Turchia | Austria | |
| Chemioterapia per carcinoma mammario | da $19,200 | da $1,200 | da $15,000 |
| Resezione dell'esofago | da $43,000 | da $21,600 | - |
| Radioterapia per il carcinoma esofageo | - | da $7,000 | da $20,000 |
| Radioterapia per il cancro colorettale | - | da $7,000 | da $12,000 |
| Halcyon | - | da $5,400 | - |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Cancro esofageo. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Cancro esofageo e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Cancro esofageo.
Il medico dirige la Divisione di Ematologia-Oncologia e si è laureato presso il College of Medicine dell'Università Nazionale di Seoul.<\/p>
È specializzato in cancro ai polmoni, cancro alla testa e al collo e cancro esofageo. È membro di diverse organizzazioni prestigiose, tra cui l'Associazione Medica Coreana, l'American Society of Clinical Oncology e l'European Society of Medical Oncology.<\/p>
Il medico è un chirurgo toracico altamente qualificato con vasta esperienza in tecniche chirurgiche minimamente invasive. Specializzandosi in procedure toraciche complesse, il medico ha eseguito con successo numerose resezioni polmonari e interventi chirurgici esofagei. Con la certificazione del consiglio in chirurgia toracica, il medico è impegnato a migliorare la cura del paziente attraverso metodi chirurgici innovativi e la partecipazione alla ricerca clinica. Il medico ha contribuito a diverse riviste peer-reviewed ed è attivamente coinvolto nell'educazione e formazione medica.<\/p>
Il medico è il Direttore del Centro Oncologico Yonsei presso il Sistema Sanitario dell'Università Yonsei a Seul, Corea del Sud. Specializzato nel trattamento del cancro gastrico avanzato, il medico ha una vasta esperienza in chirurgia, oncologia e gastroenterologia.<\/p>
Il medico ha ricoperto posizioni prestigiose come Presidente dell'Associazione Coreana del Cancro Gastrico e dell'Associazione Internazionale del Cancro Gastrico, e Presidente del Consiglio dell'Associazione Coreana del Cancro e della Società Chirurgica Coreana.<\/p>
Riconosciuto come un chirurgo eccezionale nella chirurgia del cancro gastrico, il medico ha ricevuto numerosi riconoscimenti, tra cui il Premio Accademico per il Cancro e il Premio Accademico Yuhan.<\/p>
South Korea reports a 45.7% overall 5-year survival rate for esophageal cancer. Success rates for localized stage I cancer reach 74.8%. These figures rank among the highest globally. Elite Seoul centers maintain operative mortality rates below 5% through high-volume specialization and advanced surgical technology.
Bookimed Expert Insight: Success rates in South Korea are tied to hospital volume. Elite centers like Asan Medical Center perform over 65,000 operations annually. This experience leads to better outcomes. Patients should prioritize clinics with integrated tumor boards. Specialists like Dr. Keun Chil Park at Samsung Medical Center provide multidisciplinary precision for complex cases.
Patient Consensus: Patients note that rapid diagnostic work-ups at large tertiary hospitals are life-changing. Practical concerns often focus on maintaining nutrition and swallowing ability during recovery.
Advanced esophageal cancer treatment in South Korea utilizes robotic-assisted surgery and proton therapy to target tumors precisely. Centers prioritize minimally invasive techniques like endoscopic submucosal dissection (ESD) for early-stage cases. JCI-accredited facilities integrate Novalis and IGRT systems for high-dose radiation while sparing adjacent heart and lung tissue.
Bookimed Expert Insight: Data shows a high concentration of advanced technology in Seoul, where major centers like Asan Medical Center perform over 65,000 operations annually. While basic radiation is common, advanced proton therapy is more specialized. Patients should focus on clinics like Samsung Medical Center that combine IGRT with Novalis systems for the most refined tumor targeting.
Patient Consensus: Patients note it is important to remember that minimally invasive robotic surgery still requires significant recovery time. Many emphasize that surgeon experience with high volumes is just as critical as the technology used.
Minimally invasive surgery is a primary option for early-stage esophageal cancer in South Korea. Surgeons utilize laparoscopic or robotic esophagectomy to remove tumors through small incisions. These techniques minimize blood loss and lung complications. Leading Seoul hospitals provide these procedures within JCI-accredited oncology departments.
Bookimed Expert Insight: South Korea occupies a unique leadership position in digestive tract oncology. While many countries focus on Western diseases, Korean centers like Asan Medical Center perform over 65,000 operations annually. This immense volume allows surgeons to master robotic esophagectomy faster than in lower-volume regions. This experience translates into higher precision when operating in the tight spaces of the chest cavity.
Patient Consensus: Patients note that while recovery is still demanding, the robotic approach helps them start walking earlier. They emphasize choosing high-volume centers to ensure the surgical team handles these complex procedures daily.
Korean oncology teams design esophageal cancer plans through mandatory multidisciplinary boards prioritizing regional squamous cell carcinoma. Specialists utilize high-definition endoscopy and 18F-FDG PET-CT for precise staging. Protocols emphasize tri-modality therapy. These include neoadjuvant chemoradiotherapy followed by robotic-assisted minimally invasive surgery at JCI-accredited tertiary centers.
Bookimed Expert Insight: Data from South Korea's top hospitals reveals a massive experience gap. Samsung Medical Center alone manages over 2,000,000 patients annually and performs 45,000+ operations. This extreme volume allows teams to specialize in rare sub-types of esophageal cancer. Patients can benefit from robotic surgical expertise that typically requires 1,000+ procedures to master.
Patient Consensus: Patients note that nutrition is managed as a vital part of treatment. Teams focus on weight maintenance and swallowing support immediately after diagnosis.
Locally advanced esophageal cancer has spread past the initial lining or into nearby lymph nodes but hasn't reached distant organs. South Korean centers manage these cases using aggressive multimodal strategies. Most protocols combine neoadjuvant chemoradiation and surgery to aim for complete tumor clearance.
Bookimed Expert Insight: Patient volume is a major quality signal in South Korea. Facilities like Seoul National University Hospital and Asan Medical Center handle over 1,500,000 cases annually. This massive volume allows surgeons to specialize in complex, locally advanced cases that may be declined elsewhere. Smaller centers often lack the multidisciplinary infrastructure needed for these high-risk procedures.
Patient Consensus: Patients note that maintaining diet and weight during treatment is the biggest hurdle. Many emphasize seeking evaluation at high-volume centers to ensure a personalized multimodal plan is followed.
Patients in the Republic of Korea typically begin esophageal cancer treatment within 1 to 4 weeks after staging. Leading centers like Samsung Medical Center prioritize rapid diagnostics using PET-CT and biopsy. Treatment initiation depends strictly on completing clinical staging and ensuring the patient is nutritionally stable.
Bookimed Expert Insight: South Korean oncology centers handle massive patient volumes, with Severance Hospital serving 1.6 million outpatients annually. This high throughput creates a highly efficient diagnostic loop. Our data shows that clinics like SNUH, which treats the president, often complete complex staging and histopathology in under 7 days. This speed is a major differentiator from Western systems where diagnostics alone can take weeks.
Patient Consensus: Patients note that the real wait often involves hospital scheduling and completing final lab work. Many emphasize starting nutritional support early to avoid delays if swallowing becomes too difficult before surgery.
Language barriers in South Korea are managed effectively through dedicated International Healthcare Centers at major hospitals. JCI-accredited facilities in Seoul provide professional medical interpreters and multilingual staff. These systems ensure clear communication for complex esophageal cancer treatments and surgical consent processes.
Bookimed Expert Insight: While many assume communication is the main hurdle, the true value lies in hospital digitalization. Seoul National University Hospital has used full digital records since 2004. This system allows doctors to share precise diagnostic data instantly. It reduces the need for verbal explanations of complex medical histories.
Patient Consensus: Patients note that while basic English works for navigation, a dedicated translator is vital for understanding recovery steps. They emphasize bringing printed symptom timelines to avoid confusion during busy rounds with the medical team.